Concepción García

2.3k citations

59 papers · 1.7k indexed · h-index 24

Pharmacology top 0.5%
Cellular and Molecular Neuroscience top 2%
Molecular Biology
Neurology top 5%
Plant Science top 10%

Co-authors: Javier Fernández‐Ruíz Cristina Palomo‐Garo Roger G. Pertwee Yolanda Gómez‐Gálvez Moisés Garcı́a-Arencibia Onintza Sagredo Raphael Mechoulam M. Ruth Pazos
Topics: Cannabis and Cannabinoid Research (19 papers)Neuroscience and Neuropharmacology Research (13 papers)Parkinson's Disease Mechanisms and Treatments (11 papers)
Cited by: Pharmacology Cellular and Molecular Neuroscience Biological Psychiatry
Journals: Journal of Biological Chemistry PLoS ONE The Journal of Comparative Neurology
Partner nations: Spain United Kingdom Argentina

In The Last Decade

Concepción García

56 papers receiving 1.7k citations

Peers

Countries citing papers authored by Concepción García

Since Specialization

Citations

This map shows the geographic impact of Concepción García's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Concepción García with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Concepción García more than expected).

Fields of papers citing papers by Concepción García

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Concepción García. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Concepción García. The network helps show where Concepción García may publish in the future.

Co-authorship network of co-authors of Concepción García

This figure shows the co-authorship network connecting the top 25 collaborators of Concepción García. A scholar is included among the top collaborators of Concepción García based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Concepción García. Concepción García is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Investigation in the CB1 and CB2 receptor binding profile and intrinsic activity of (−) and (+)-enantiomers of some naturally occurring phytocannabinoids or synthetic derivatives 2025 ·European Journal of Medicinal Chemistry Reports ·(unknown),María Gómez‐Cañas,(unknown),(unknown),Mathias Winkler,Diego Caprioglio,Giovanni Appendino,Concepción García,Paula Morales,Nadine Jagerovic,(unknown),Bernd L. Fiebich,(unknown),Eduardo Muñóz,Javier Fernández‐Ruíz	1
2	Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson’s Disease and Amyotrophic Lateral Sclerosis 2021 ·Molecules ·(unknown),Concepción García,(unknown),(unknown),Francisco Ruíz-Pino,Juan D. Unciti‐Broceta,María Gómez‐Cañas,(unknown),Paula Morales,Nadine Jagerovic,Carmen Rodríguez‐Cueto,Eva de Lago,Eduardo Muñóz,Javier Fernández‐Ruíz	16
3	Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson’s Disease 2021 ·Molecules ·(unknown),Concepción García,María Gómez‐Cañas,Alain Rolland,Eduardo Muñóz,Javier Fernández‐Ruíz	23
4	Neuroprotection with the cannabigerol quinone derivative VCE-003.2 and its analogs CBGA-Q and CBGA-Q-Salt in Parkinson's disease using 6-hydroxydopamine-lesioned mice 2020 ·Molecular and Cellular Neuroscience ·(unknown),Concepción García,María Gómez‐Cañas,Carmen Navarrete,Adela García‐Martín,Alain Rolland,Carmen del Río,Marı́a José Casarejos,Eva Muñoz,(unknown),Eduardo Muñóz,Javier Fernández‐Ruíz	23
5	Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease 2019 ·Molecules ·(unknown),Concepción García,María Gómez‐Cañas,Eduardo Muñóz,Javier Fernández‐Ruíz	31
6	Molecular epidemiology, genotype–phenotype correlation and BH4 responsiveness in Spanish patients with phenylketonuria 2016 ·Journal of Human Genetics ·Luis Aldámiz‐Echevarría,Marta Llarena,(unknown),Jaime Dalmau,Isidro Vitoria,Ana Fernández‐Marmiesse,Fernando Andrade,Javier Blasco‐Alonso,Carlos Losilla Alcalde,David Gil,Concepción García,Domingo González‐Lamuño,Mónica Ruiz,(unknown),Luis Peña Quintana,David González,Félix Sánchez‐Valverde,Lourdes R. Desviat,Belén Pérez,María L. Couce	29
7	Impacto asistencial y económico de la ecografía tiroidea en acto único en consultas de endocrinología (estudio ETIEN 1) 2015 ·Endocrinología y Nutrición ·Florentino Carral,(unknown),Ana I. Jiménez,Concepción García	8
8	Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson’s disease 2014 ·Neuroscience Letters ·Concepción García,Valentina Cinquina,Cristina Palomo‐Garo,Alberto Rábano,Javier Fernández‐Ruíz	81
9	Tetrahydrobiopterin therapy vs phenylalanine-restricted diet: Impact on growth in PKU 2013 ·Molecular Genetics and Metabolism ·Luis Aldámiz‐Echevarría,(unknown),María L. Couce,Sergio Lage,Jaime Dalmau,Isidro Vitoria,Fernando Andrade,Marta Llarena,Javier Blasco‐Alonso,Carlos Losilla Alcalde,David Gil,Concepción García,Domingo González‐Lamuño,Mónica Ruiz,(unknown),David González,Félix Sánchez‐Valverde	23
10	Subchronic Toxicity of the New Quinolone Antibacterial Agent Irloxacin in Beagle Dogs 2011 ·Arzneimittelforschung ·(unknown),Concepción García,(unknown)	2
11	Pectinolytic enzyme production by Colletotrichum truncatum, causal agent of soybean anthracnose 2010 ·Revista Iberoamericana de Micología ·Araceli Marcela Ramos,(unknown),Concepción García,Laura Levin	26
12	Different Susceptibility to the Parkinson's Toxin MPTP in Mice Lacking the Redox Master Regulator Nrf2 or Its Target Gene Heme Oxygenase-1 2010 ·PLoS ONE ·Nadia G. Innamorato,Agnieszka Jaźwa,Ana I. Rojo,Concepción García,Javier Fernández‐Ruíz,Anna Grochot‐Przeczek,Anna Stachurska,Alicja Józkowicz,Józef Dulak,Antonio Cuadrado	117
13	Evaluation of the genotoxic potential of three phenyltetrahydropyridinyl butylazole-derived sigma-receptor ligand drug candidates 2008 ·Mutation Research/Genetic Toxicology and Environmental Mutagenesis ·(unknown),Concepción García,(unknown),(unknown),Antonio R. Fernández de Henestrosa,María Teresa Ruiz,(unknown),(unknown),Ricard Marcos	6
14	Induction of hypothermic conditions associated with increased micronuclei formation in sigma‐1 receptor knockout mice after administration of the antipsychotic compound E‐5842 2008 ·Environmental and Molecular Mutagenesis ·(unknown),(unknown),Concepción García,Antonio R. Fernández de Henestrosa,María Teresa Ruiz,(unknown),Ricard Marcos	3
15	Estudio Lactancia en Área Hospital de Alcañiz.¿Merece la pena poner en práctica los diez pasos de la Iniciativa Hospital Amigode los Niños en un hospital comarcal? 2006 ·Dialnet (Universidad de la Rioja) ·(unknown),(unknown),(unknown),Concepción García,(unknown)	1
16	Opposite roles of D1 and D5 dopamine receptors in locomotion revealed by selective antisense oligonucleotides 1998 ·Neuroreport ·Gustavo Dziewczapolski,Liliana Menalled,Concepción García,(unknown),Oscar S. Gershanik,Marcelo Rubinstein	58
17	Central Olfactory Structures in Pax‐6 Mutant Mice^a 1998 ·Annals of the New York Academy of Sciences ·Laura López‐Mascaraque,Concepción García,F. Valverde,Juan Carlos	27
18	Producción gástrica de óxido nítrico y monóxido de carbono en un modelo experimental de sepsis. Efecto de pentoxifilina y somatostatina 1998 ·Cirugía Española ·José‐Ángel Hernández‐Rivas,Javier Arias‐Díaz,Natividad Villa,Concepción García,Elena Vara,(unknown)	1
19	Antiplatelet therapy and development of hypertension induced by recombinant human erythropoietin in uremic patients 1994 ·Kidney International ·Francisco Caravaca,J.L. Pizarro,(unknown),Juan José Cubero,Concepción García,Manuel Pérez‐Miranda	25
20	Catalogación "on line" y eficacia de la recuperación 1990 ·Boletín de la ANABAD ·Félix de Moya Anegón,Javier López Gijón,Concepción García	1

About Concepción García

Concepción García is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Clinical Biochemistry, having authored 59 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (19 papers), Neuroscience and Neuropharmacology Research (13 papers) and Parkinson's Disease Mechanisms and Treatments (11 papers). The work is most often cited by research in Pharmacology (1.0k citations), Cellular and Molecular Neuroscience (757 citations) and Biological Psychiatry (78 citations). Concepción García has collaborated with scholars based in Spain, United Kingdom and Argentina. Frequent co-authors include Javier Fernández‐Ruíz, Cristina Palomo‐Garo, Roger G. Pertwee, Yolanda Gómez‐Gálvez, Moisés Garcı́a-Arencibia, Onintza Sagredo, Raphael Mechoulam, M. Ruth Pazos, José Martínez‐Orgado and Jaime A. Ramos. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and The Journal of Comparative Neurology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact